Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

November 4, 2026 updated by: Contineum Therapeutics

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Oral PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

This is a Ph 2, randomized, double-blind, placebo-controlled global multicenter study to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of PIPE-791 in participants with a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) with or without background treatment.

Study Overview

Detailed Description

This is a Ph 2, randomized, double-blind, placebo-controlled global multicenter study to evaluate the efficacy, safety, tolerability, and PK of PIPE-791 in participants with a diagnosis of Idiopathic Pulmonary Fibrosis with or without background treatment. The treatment period is 26 weeks and full study duration is up to 36 weeks including Screening and Follow-Up. Approximately 324 participants will be enrolled into one of three treatment arms, PIPE-791 Dose A, PIPE-791 Dose B, or placebo.

Study Type

Interventional

Enrollment (Estimated)

324

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Buenos Aires, Argentina, C1023AAB
        • Recruiting
        • STAT Research S.A.
      • Buenos Aires, Argentina, C1425FVH
        • Recruiting
        • Consultorios Médicos Organización del Buen Ayre SRL
      • Buenos Aires, Argentina, C1426ABP
        • Recruiting
        • Centro Médico Dra de Salvo - Fundacion Respirar - PPDS
      • Córdoba, Argentina, X5003DCE
        • Recruiting
        • Instituto de Medicina Respiratoria - IMER
      • Santa Fe, Argentina, S3000ASF
        • Recruiting
        • IbaMedica
    • Buenos Aires
      • Mar del Plata, Buenos Aires, Argentina, B7602DCK
        • Recruiting
        • Instituto Ave Pulmo
      • Quilmes, Buenos Aires, Argentina, B1878FNR
        • Recruiting
        • Centro Respiratorio Quilmes
    • Buenos Aires F.D.
      • Buenos Aires, Buenos Aires F.D., Argentina, C1056ABI
        • Recruiting
        • CINME S.A. - Centro de Investigaciones Metabólicas - Viamonte 2213/2215
    • Santa Fe Province
      • Rosario, Santa Fe Province, Argentina, S2000DBS
        • Recruiting
        • Instituto de Especialidades de la Salud Rosario - Clínica del Tórax
      • Rosario, Santa Fe Province, Argentina, S2000DEJ
        • Recruiting
        • Instituto Médico de la Fundación Estudios Clínicos
      • San Luis, Santa Fe Province, Argentina, S3000GBL
        • Recruiting
        • Centro de Diagnóstico Y Rehabilitación - Santa Fe - San Luis
    • Tucumán Province
      • San Miguel de Tucumán, Tucumán Province, Argentina, T4000AXL
        • Recruiting
        • Centro de Investigaciones Médicas Tucumán - PPDS
      • San Miguel de Tucumán, Tucumán Province, Argentina, T4000IAP
        • Recruiting
        • IPR-Investigaciones en Patologías Respiratorias
      • San Miguel de Tucumán, Tucumán Province, Argentina, T4000CBC
        • Recruiting
        • CIMER-Centro Integral de Medicina Respiratoria
      • San Miguel de Tucumán, Tucumán Province, Argentina, T4000IFL
        • Recruiting
        • Centro Modelo de Cardiología-Laprida 554
    • New South Wales
      • Camperdown, New South Wales, Australia, 2050
        • Recruiting
        • Royal Prince Alfred Hospital
      • Westmead, New South Wales, Australia, 2145
        • Recruiting
        • Westmead Hospital
    • Queensland
      • Chermside, Queensland, Australia, 4032
        • Recruiting
        • Lung Research Qld
      • Chermside, Queensland, Australia, 4032
        • Recruiting
        • The Prince Charles Hospital
      • Greenslopes, Queensland, Australia, 4120
        • Recruiting
        • Greenslopes Private Hospital
    • Victoria
      • Heidelberg, Victoria, Australia, 3084
        • Recruiting
        • Austin Health
      • Melbourne, Victoria, Australia, 3004
        • Recruiting
        • The Alfred Hospital
    • Western Australia
      • Midland, Western Australia, Australia, 6056
        • Recruiting
        • Institute for Respiratory Health
      • Spearwood, Western Australia, Australia, 6163
        • Recruiting
        • TrialsWest Pty Ltd
      • Brussels, Belgium, 1200
        • Recruiting
        • Cliniques Universitaires Saint-Luc - PPDS
      • Yvoir, Belgium, 5530
        • Recruiting
        • CHU UCL Namur - Site Godinne
    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z 1M9
        • Recruiting
        • Vancouver General Hospital
    • Ontario
      • Ajax, Ontario, Canada, L1S 2J5
        • Recruiting
        • Dynamic Drug Advancement Ltd.
      • Toronto, Ontario, Canada, M5G 2C4
        • Recruiting
        • Toronto General Hospital
      • Windsor, Ontario, Canada, N8X 5A6
        • Recruiting
        • Dr. Anil Dhar Medicine Professional Corporation
    • Quebec
      • Montreal, Quebec, Canada, H2X 0A9
        • Recruiting
        • Centre Hospitalier de l'Universite de Montreal
      • Québec, Quebec, Canada, G1V 4G5
        • Recruiting
        • Institut Universitaire de Cardiologie et de Pneumologie de Quebec - Université Laval
    • Quebec City
      • Trois-Rivières, Quebec City, Canada, G8T 7A1
        • Recruiting
        • Centre d'investigation Clinique Mauricie
    • Maule Region
      • Curicó, Maule Region, Chile, 3341643
        • Recruiting
        • Centro de Investigacion Curicó
    • Santiago Metropolitan
      • Santiago, Santiago Metropolitan, Chile, 8320000
        • Recruiting
        • Biocinetic Servicios Medicos Ltda
      • Ñuñoa, Santiago Metropolitan, Chile, 7750495
        • Recruiting
        • CEC SpA
    • Valparaiso
      • Viña del Mar, Valparaiso, Chile, 2520000
        • Recruiting
        • Centro de Investigacion de Enfermedades Respiratorias e Inmunologicas
      • Viña del Mar, Valparaiso, Chile, 2520000
        • Recruiting
        • Centro de Investigaciones Clinicas Vina del Mar
    • Region Syddanmark
      • Odense C, Region Syddanmark, Denmark, 5000
        • Recruiting
        • Odense Universitetshospital
      • Bron, France, 69500
        • Recruiting
        • Hospices Civils de Lyon - Groupement Hospitalier Est
    • Alpes-Maritimes
      • Nice, Alpes-Maritimes, France, 6001
        • Recruiting
        • CHU de Nice-Hôpital Pasteur
    • Bouches-du-Rhône
      • Marseille, Bouches-du-Rhône, France, 13915
        • Recruiting
        • AP-HM - Hôpital Nord
    • Ille-et-Vilaine
      • Rennes, Ille-et-Vilaine, France, 35000
        • Recruiting
        • CHU de Rennes - Hôpital Pontchaillou
    • Seine-Saint-Denis
      • Bobigny, Seine-Saint-Denis, France, 93000
        • Recruiting
        • AP-HP - Hopital Avicenne
    • Somme
      • Amiens, Somme, France, 80054
        • Recruiting
        • CHU Amiens Picardie - Site Sud
    • Hesse
      • Giessen, Hesse, Germany, 35392
        • Recruiting
        • Universitätsklinikum Gießen und Marburg GmbH - Standort Gießen
    • Achaïa
      • Pátrai, Achaïa, Greece, 265 04
        • Recruiting
        • University General Hospital of Patras
    • Anatoliki Attiki
      • Athens, Anatoliki Attiki, Greece, 115 27
        • Recruiting
        • Thoracic General Hospital of Athens I SOTIRIA
      • Chaïdári, Anatoliki Attiki, Greece, 124 62
        • Recruiting
        • University General Hospital - General Hospital of West Attica H Agia Varvara
    • Evros
      • Alexandroupoli, Evros, Greece, 681 00
        • Recruiting
        • University General Hospital of Alexandroupolis
    • Ioannina
      • Ioannina, Ioannina, Greece, 455 00
        • Recruiting
        • University General Hospital of Ioannina
    • Irakleio
      • Heraklion, Irakleio, Greece, 715 00
        • Recruiting
        • PAGNI-University General Hospital of Heraklion
    • Thessaloniki
      • Exochi, Thessaloniki, Greece, 570 10
        • Recruiting
        • General Hospital of Thessaloniki ''G. Papanikolaou''
      • Tel Aviv, Israel, 6423906
        • Recruiting
        • Tel Aviv Sourasky Medical Center Ichilov - PPDS
    • Central District
      • Be’er Ya‘aqov, Central District, Israel, 7033001
        • Recruiting
        • Shamir Medical Center
      • Kafr Saba, Central District, Israel, 4428164
        • Recruiting
        • Meir Medical Center
      • Petah Tikva, Central District, Israel, 4941492
        • Recruiting
        • Rabin Medical Center - PPDS
      • Ramat Gan, Central District, Israel, 5262100
        • Recruiting
        • The Chaim Sheba Medical Center - PPDS
      • Rehovot, Central District, Israel, 7661041
        • Recruiting
        • Kaplan Medical Center
    • Haifa District
      • Hadera, Haifa District, Israel, 3820302
        • Recruiting
        • Hillel Yaffe Medical Center
    • Jerusalem
      • Jerusalem, Jerusalem, Israel, 9112001
        • Recruiting
        • Hadassah Medical Center- Ein Kerem - PPDS
    • Southern District
      • Ashdod, Southern District, Israel, 7747629
        • Recruiting
        • Assuta Ashdod University Medical Center
      • Ashkelon, Southern District, Israel, 7830604
        • Recruiting
        • The Barzilai University Medical Center
    • Yerushala
      • Jerusalem, Yerushala, Israel, 9103102
        • Recruiting
        • Shaare Zedek Medical Center
    • Auckland
      • Epsom, Auckland, New Zealand, 1051
        • Recruiting
        • Greenlane Clinical Centre
      • Papatoetoe, Auckland, New Zealand, 2025
        • Recruiting
        • Aotearoa Clinical Trials Trust - Middlemore Hospital - PPDS
    • Canterbury
      • Christchurch, Canterbury, New Zealand, 8001
        • Recruiting
        • Canterbury Respiratory Research Group
    • Waikato Region
      • Hamilton, Waikato Region, New Zealand, 3240
        • Recruiting
        • Health New Zealand - Te Whatu Ora - Waikato Hospital
    • Lima Province
      • Lima, Lima Province, Peru, 15001
        • Recruiting
        • Clinica Internacional - PPDS
      • Lima, Lima Province, Peru, 15046
        • Recruiting
        • Clinica Ricardo Palma - PPDS
    • Lima region
      • Chancay, Lima region, Peru, 15131
        • Recruiting
        • Hospital Chancay y Servicios Basicos de Salud
      • San Miguel, Lima region, Peru, 15001
        • Recruiting
        • Clinica Providencia - PPDS
      • Surco, Lima region, Peru, 15555
        • Recruiting
        • Clinica San Pablo Surco
    • Kuyavian-Pomeranian Voivodeship
      • Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland, 85-079
        • Recruiting
        • SpiroClinic
    • Lublin Voivodeship
      • Świdnik, Lublin Voivodeship, Poland, 21-040
        • Recruiting
        • Alergopneuma Centrum Medyczne - Swidnik
    • Podlaskie Voivodeship
      • Bialystok, Podlaskie Voivodeship, Poland, 15-044
        • Recruiting
        • Centrum Medycyny Oddechowej Mroz sp. j.
    • Silesian Voivodeship
      • Sosnowiec, Silesian Voivodeship, Poland, 41-208
        • Recruiting
        • PULMAG s.c.
      • Lisbon, Portugal, 1169-024
        • Recruiting
        • ULS de São José, EPE - Hospital de Santa Marta
      • Belgrade, Serbia, 11000
        • Recruiting
        • University Clinical Center of Serbia - Koste Todorovica - PPDS
      • Kragujevac, Serbia, 34000
        • Recruiting
        • University Clinical Center Kragujevac
      • Niš, Serbia, 18 000
        • Recruiting
        • University Clinical Center Nis
    • Syrmia
      • Kamenitz, Syrmia, Serbia, 21204
        • Recruiting
        • Institute of Pulmonary Diseases of Vojvodina
      • Incheon, South Korea, 21565
        • Recruiting
        • Gachon University Gil Medical Center
      • Seoul, South Korea, 2841
        • Recruiting
        • Korea University Anam Hospital
    • Eunpyeong District
      • Seoul, Eunpyeong District, South Korea, 03312
        • Recruiting
        • The Catholic University of Korea - Eunpyeong St. Mary's Hospital
    • Gyeonggi-do
      • Bucheon-si, Gyeonggi-do, South Korea, 14647
        • Recruiting
        • The Catholic University of Korea, Bucheon St. Mary's Hospital
      • Seongnam-si, Gyeonggi-do, South Korea, 13620
        • Recruiting
        • Seoul National University Bundang Hospital
    • Seodaemun
      • Seoul, Seodaemun, South Korea, 03722
        • Recruiting
        • Severance Hospital Yonsei University Health System
    • Seoul
      • Seoul, Seoul, South Korea, 06351
        • Recruiting
        • Samsung Medical Center
      • Songpa-dong, Seoul, South Korea, 05505
        • Recruiting
        • Asan Medical Center
    • Yongsan-gu
      • Seoul, Yongsan-gu, South Korea, 04401
        • Recruiting
        • Soon Chun Hyang University Hospital
      • Madrid, Spain, 28031
        • Recruiting
        • Hospital Universitario Infanta Leonor
    • A Coruña
      • Santiago de Compostela, A Coruña, Spain, 15706
        • Recruiting
        • CHUS-Hospital Clinico Universitario de Santiago
    • Malaga
      • Málaga, Malaga, Spain, 29010
        • Recruiting
        • Hospital Universitario Virgen de la Victoria
    • Valencia
      • Valencia, Valencia, Spain, 46010
        • Recruiting
        • Hospital Clinico Universitario de Valencia
      • Changhua, Taiwan, 50006
        • Recruiting
        • Changhua Christian Hospital
      • Kaohsiung City, Taiwan, 80756
        • Recruiting
        • Kaohsiung Medical University - Chung-Ho Memorial Hospital
      • New Taipei City, Taiwan, 220
        • Recruiting
        • Far Eastern Memorial Hospital
      • Taichung, Taiwan, 407219
        • Recruiting
        • Taichung Veterans General Hospital
      • Taipei, Taiwan, 112201
        • Recruiting
        • Taipei Veterans General Hospital
      • Taipei, Taiwan, 106
        • Recruiting
        • National Taiwan University Hospital
      • Birmingham, United Kingdom, B3 3HX
        • Recruiting
        • Birmingham Heartlands Hospital
      • London, United Kingdom, SW3 6NP
        • Recruiting
        • Royal Brompton Hospital
    • England
      • Leicester, England, United Kingdom, LE3 9QP
        • Recruiting
        • NIHR Leicester Biomedical Research Centre - Glenfield Hospital
    • Greater London
      • London, Greater London, United Kingdom, EC1A 7BE
        • Recruiting
        • St Bartholomew's Hospital - PPDS
    • Hampshire
      • Southampton, Hampshire, United Kingdom, SO16 6YD
        • Recruiting
        • Southampton General Hospital
    • Scotland
      • Edinburgh, Scotland, United Kingdom, EH16 4SA
        • Recruiting
        • Royal Infirmary of Edinburgh
      • Perth, Scotland, United Kingdom, PH1 1NX
        • Recruiting
        • Perth Royal Infirmary

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Key Inclusion Criteria:

  • Male or female ≥ 40 years of age at the time of Randomization.
  • A diagnosis of IPF within 7 years prior to Screening, based on the 2022 ATS/ERS/JRS/ALAT practice guideline as confirmed by the Investigator, and a centrally read screening HRCT consistent with usual interstitial pneumonia (UIP) or probable UIP.
  • Percent predicted (pp) FVC ≥ 40% on Screening spirometry.
  • Participants may enter the study whether or not they are receiving background nintedanib or pirfenidone therapy approved for the treatment of IPF, but not both concurrently.

Key Exclusion Criteria:

  • Those with a history of interstitial lung disease (ILD) other than IPF are not eligible.
  • Those with pulmonary arterial hypertension (PAH) requiring multi-drug therapy are not eligible.
  • Those who have experienced an IPF exacerbation within 6 weeks of Screening, or during Screening, are not eligible.
  • Those with an estimated glomerular filtration rate (eGFR) ≤ 30 ml/min/1.73 m2 (Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI] formula) (Inker 2021) or who have Child-Pugh Class B or C hepatic impairment are not eligible.
  • Female participants must not be of childbearing potential.

Additional inclusion and exclusion criteria apply.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo

Participants will receive a daily oral dose of matching Placebo in tablet form

Experimental: PIPE-791 Dose A

Participants will receive a daily oral dose of PIPE-791 in tablet form

Other Names:
  • PIPE-791
Experimental: PIPE-791 Dose B

Participants will receive a daily oral dose of PIPE-791 in tablet form

Other Names:
  • PIPE-791

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Absolute change in forced vital capacity (FVC) (mL)
Time Frame: From baseline to Week 26
From baseline to Week 26

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To investigate the safety and tolerability of PIPE-791 compared to placebo based on percentage of treatment-emergent adverse events (TEAE)
Time Frame: From baseline to Week 30
From baseline to Week 30
Time to first ≥10% absolute decline in ppFVC
Time Frame: From baseline to time of first ≥10% absolute decline, up to Week 26
From baseline to time of first ≥10% absolute decline, up to Week 26
Proportion of participants with a ≥10% absolute decline in percent predicted FVC (ppFVC)
Time Frame: From baseline to Weeks 12 and Week 26
From baseline to Weeks 12 and Week 26
Relative change in FVC (mL)
Time Frame: From baseline to Week 26

Additional assessment of disease progression through lung function measurements

From baseline to Week 26
Absolute change in ppFVC
Time Frame: From baseline to Week 26

Additional assessment of disease progression through lung function measurements

From baseline to Week 26
Relative change in ppFVC
Time Frame: From baseline to Week 26

Additional assessment of disease progression through lung function measurements

From baseline to Week 26
Change in quantitative CT-derived lung fibrosis burden on HRCT
Time Frame: From baseline to Week 26

Additional assessment of disease progression through imaging

From baseline to Week 26

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mudiaga O Sowho, MD, MPH, Contineum Therapeutics

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2026

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

June 1, 2028

Study Registration Dates

First Submitted

December 8, 2025

First Submitted That Met QC Criteria

December 8, 2025

First Posted (Actual)

December 16, 2025

Study Record Updates

Last Update Posted (Actual)

November 5, 2026

Last Update Submitted That Met QC Criteria

November 4, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe